Parkinson’s podcast: stopping disease progression

Resources & Tools

Author: Geoffrey ChangPublished: 9 July 2015

Prep: Cook: Serves:

In the second episode of the Portland Countdown podcast series, Dr Patrik Brundin and Dr Kimberley Gannon discuss how to stop ‘bad’ proteins attacking brain cells

Stopping disease progression: alpha synuclein

Special Guests: Patrik Brundin, MD, PhD and Kimberley Gannon, PhD

Basic researchers are hard at work trying to understand the pathology of Parkinson’s and discover new drug targets. One likely bad actor is a protein called alpha-synuclein.

Hosted by Dave Iverson and Jon Palfreman, Emmy award-winning journalists living with Parkinson’s disease, this episode looks into what we know about how alpha-synuclein kills brain cells and what might be done to stop it, with Dr Patrik Brundin and Dr Kimberley Gannon on hand to offer their expert opinions.

The aim of the Portland Countdown series is to give listeners new perspectives on the latest advances in Parkinson’s research and treatment.

The shows, developed by the World Parkinson Coalition, are aired online on the first Tuesday of every month from June 2015 to September 2016 – when the 4th World Parkinson Congress takes place in Portland, Oregon, USA. The entire series of podcasts will also be downloadable for free.

The full schedule of show topics and guest speaker profiles is available here

Last Month

Next Month

Go Back

Share this story

Comments

Global update

Support Parkinson’s organisations across the world on #GivingTuesday

The Big Give, the MJFF and the APDA to match-fund donations

Regular sex improves Parkinson’s symptoms for men, study finds

Regular sex can lessen effects of Parkinson’s in men

New Parkinson’s love story set to hit the big screen

“Love conquers all”

Scientists at MIT uncover new clues about Parkinson’s disease

Neuroscientists at Massachusetts Institute of Technology (MIT), US, have developed new tools that could improve understanding of Parkinson’s disease. As part of a study, published in Science Advances, the tools were used on animals to investigate the relationship between two types of signals that are disrupted in Parkinson’s – dopamine signalling and beta-band oscillations (coordinated waves of electrical activity in the brain). The scientists found that while the animals performed certain tasks, beta-band oscillations increased while dopamine signalling declined in particular parts of the brain. Factors including an animal’s past experience and the reward value of a task also impacted the relationship between the two signals. Helen Schwerdt, a research scientist at MIT, said: “Considering electrical signals side by side with chemical signals is really important to understand how the brain works.” Ann Graybiel, a professor at MIT, added: “As these methods in neuroscience become more and more precise and…

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

A new database study of around 80,000 Covid-19 patients has found that those living with Parkinson’s disease have a 30% higher risk of dying from the virus than those without the condition. The study – conducted by researchers at the University of Iowa Health Care, US – identified that Covid-19 patients with Parkinson’s disease were generally older, more likely to be male and less likely to be African American. As these factors could also affect the risk of death from Covid-19, the researchers adjusted their statistical models to account for differences in sex, age and race and found a significantly higher risk of dying from Covid-19 in the group of patients with Parkinson’s disease. Lead researcher Dr Nandakumar Narayanan said: “We recognise the limitations of this study; it is retrospective data from a single database, but we are confident that these data show that Parkinson’s disease is [an] independent risk factor…

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

Portugal-based pharmaceutical company BIAL has launched a new research centre, BIAL Biotech, in Massachusetts, US, which will focus on genetically defined Parkinson’s disease. BIAL has also announced that it has acquired the Parkinson’s disease research programmes of Lysosomal Therapeutics Inc, as well as its research and development team and clinical programme for LTI-291 – a therapy designed to treat a genetic form of the condition. António Portela, executive president of BIAL, said: “Our entry into the US with the creation of BIAL Biotech and the acquisition of the promising programmes from LTI, is a decisive step towards the fulfilment of our mission to contribute to improving the quality of life of people worldwide. “The development of this new research centre in the US, is a landmark of enormous relevance for us. We are investing in science and research, through our direct presence in one of the most important research hubs…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Parkinson’s podcast: stopping disease progression

Resources & Tools

Author: Geoffrey ChangPublished: 9 July 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Global update

Support Parkinson’s organisations across the world on #GivingTuesday

Special reports

Regular sex improves Parkinson’s symptoms for men, study finds

Interviews

New Parkinson’s love story set to hit the big screen

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Parkinson’s podcast: stopping disease progression

Resources & Tools

Author: Geoffrey ChangPublished: 9 July 2015

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Global update

Support Parkinson’s organisations across the world on #GivingTuesday

Special reports

Regular sex improves Parkinson’s symptoms for men, study finds

Interviews

New Parkinson’s love story set to hit the big screen

Scientists at MIT uncover new clues about Parkinson’s disease

People with Parkinson’s disease have a higher risk of dying from Covid-19, study finds

BIAL enters the US and acquires “promising” Parkinson’s disease programmes

{title}

Subscribe

Sign in